MGNX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Macrogenics Inc (MGNX).


$203.98M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

MGNX Market Cap. (MRY)


MGNX Shares Outstanding (MRY)


MGNX Assets (MRY)


Total Assets

$261.65M

Total Liabilities

$145.60M

Total Investments

$18.83M

MGNX Income (MRY)


Revenue

$149.96M

Net Income

-$66.97M

Operating Expense

$248.24M

MGNX Cash Flow (MRY)


CF Operations

-$68.37M

CF Investing

$149.30M

CF Financing

$960.00K

MGNX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

MGNX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$261,655,000 (-12.32%)

$298,418,000 (6.40%)

$280,468,000 (-16.34%)

$335,245,000 (-11.48%)

Assets Current

$217,490,000 (-13.47%)

$251,339,000 (13.12%)

$222,180,000 (-20.53%)

$279,560,000 (-10.57%)

Assets Non-Current

$44,165,000 (-6.19%)

$47,079,000 (-19.23%)

$58,288,000 (4.67%)

$55,685,000 (-15.82%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$116,057,000 (-23.95%)

$152,613,000 (7.46%)

$142,013,000 (-40.73%)

$239,618,000 (-19.02%)

Property Plant & Equipment Net

$42,609,000 (-6.75%)

$45,693,000 (-19.71%)

$56,910,000 (4.83%)

$54,290,000 (28.57%)

Cash & Equivalents

$182,840,000 (81.11%)

$100,956,000 (-7.28%)

$108,884,000 (-11.81%)

$123,469,000 (-31.83%)

Accumulated Other Comprehensive Income

$4,000 (166.67%)

-$6,000 (-20.00%)

-$5,000 (91.80%)

-$61,000 (-771.43%)

Deferred Revenue

$71,822,000 (-11.21%)

$80,894,000 (16.45%)

$69,468,000 (236.47%)

$20,646,000 (81.39%)

Total Investments

$18,827,000 (-85.39%)

$128,849,000 (183.42%)

$45,462,000 (-62.16%)

$120,147,000 (31.45%)

Investments Current

$18,827,000 (-85.39%)

$128,849,000 (183.42%)

$45,462,000 (-62.16%)

$120,147,000 (31.45%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$1,221,000 (-15.85%)

$1,451,000 (-66.93%)

$4,388,000 (0%)

Trade & Non-Trade Receivables

$4,309,000 (-58.44%)

$10,367,000 (-81.56%)

$56,222,000 (441.32%)

$10,386,000 (-55.00%)

Trade & Non-Trade Payables

$5,013,000 (-22.19%)

$6,443,000 (31.52%)

$4,899,000 (-68.39%)

$15,500,000 (93.00%)

Accumulated Retained Earnings (Deficit)

-$1,169,718,000 (-6.07%)

-$1,102,752,000 (-0.83%)

-$1,093,694,000 (-12.30%)

-$973,936,000 (-26.19%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$37,461,000 (10.27%)

$33,971,000 (-2.47%)

$34,832,000 (36.77%)

$25,468,000 (-12.92%)

Debt Current

$4,864,000 (28.85%)

$3,775,000 (-20.12%)

$4,726,000 (1.05%)

$4,677,000 (17.28%)

Debt Non-Current

$32,597,000 (7.95%)

$30,196,000 (0.30%)

$30,106,000 (44.80%)

$20,791,000 (-17.69%)

Total Liabilities

$145,598,000 (-0.14%)

$145,805,000 (5.31%)

$138,455,000 (44.79%)

$95,627,000 (15.41%)

Liabilities Current

$55,530,000 (-1.03%)

$56,108,000 (15.42%)

$48,611,000 (-34.82%)

$74,578,000 (47.18%)

Liabilities Non-Current

$90,068,000 (0.41%)

$89,697,000 (-0.16%)

$89,844,000 (326.83%)

$21,049,000 (-34.60%)

MGNX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$149,962,000 (155.26%)

$58,749,000 (-61.33%)

$151,941,000 (96.19%)

$77,447,000 (-26.16%)

Cost of Revenue

$12,299,000 (49.59%)

$8,222,000 (11.35%)

$7,384,000 (178.54%)

$2,651,000 (0%)

Selling General & Administrative Expense

$71,047,000 (36.14%)

$52,188,000 (-11.47%)

$58,949,000 (-6.45%)

$63,014,000 (47.43%)

Research & Development Expense

$177,194,000 (6.37%)

$166,583,000 (-19.54%)

$207,026,000 (-3.52%)

$214,577,000 (11.06%)

Operating Expenses

$248,241,000 (13.47%)

$218,771,000 (-17.75%)

$265,975,000 (-4.18%)

$277,591,000 (17.65%)

Interest Expense

$1,115,000 (-22.03%)

$1,430,000 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$944,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$66,966,000 (-639.30%)

-$9,058,000 (92.44%)

-$119,758,000 (40.75%)

-$202,115,000 (-55.79%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$66,966,000 (-639.30%)

-$9,058,000 (92.44%)

-$119,758,000 (40.75%)

-$202,115,000 (-55.79%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$66,966,000 (-639.30%)

-$9,058,000 (92.44%)

-$119,758,000 (40.75%)

-$202,115,000 (-55.79%)

Weighted Average Shares

$62,621,185 (1.12%)

$61,929,198 (0.81%)

$61,433,124 (2.48%)

$59,944,717 (14.31%)

Weighted Average Shares Diluted

$62,621,185 (1.12%)

$61,929,198 (0.81%)

$61,433,124 (2.48%)

$59,944,717 (14.31%)

Earning Before Interest & Taxes (EBIT)

-$64,907,000 (-750.90%)

-$7,628,000 (93.63%)

-$119,758,000 (40.75%)

-$202,115,000 (-55.79%)

Gross Profit

$137,663,000 (172.45%)

$50,527,000 (-65.05%)

$144,557,000 (93.27%)

$74,796,000 (-28.69%)

Operating Income

-$110,578,000 (34.28%)

-$168,244,000 (-38.57%)

-$121,418,000 (40.13%)

-$202,795,000 (-54.73%)

MGNX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$149,297,000 (286.43%)

-$80,084,000 (-213.25%)

$70,715,000 (293.16%)

-$36,609,000 (-370.25%)

Net Cash Flow from Financing

$960,000 (-99.36%)

$150,361,000 (8963.35%)

$1,659,000 (-98.65%)

$122,777,000 (-29.58%)

Net Cash Flow from Operations

-$68,373,000 (12.57%)

-$78,205,000 (10.07%)

-$86,959,000 (39.54%)

-$143,830,000 (-28.54%)

Net Cash Flow / Change in Cash & Cash Equivalents

$81,884,000 (1132.85%)

-$7,928,000 (45.64%)

-$14,585,000 (74.71%)

-$57,662,000 (-205.49%)

Net Cash Flow - Business Acquisitions and Disposals

$40,000,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$112,843,000 (243.96%)

-$78,384,000 (-205.44%)

$74,338,000 (344.47%)

-$30,408,000 (-1518.31%)

Capital Expenditure

-$3,546,000 (-108.59%)

-$1,700,000 (53.08%)

-$3,623,000 (41.57%)

-$6,201,000 (-4.99%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$149,498,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$3,435,000 (193.84%)

$1,169,000 (-29.54%)

$1,659,000 (-98.65%)

$122,777,000 (-29.58%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$29,439,000 (60.23%)

$18,373,000 (-10.10%)

$20,438,000 (-11.62%)

$23,126,000 (11.85%)

Depreciation Amortization & Accretion

$6,877,000 (-47.64%)

$13,134,000 (10.70%)

$11,865,000 (5.39%)

$11,258,000 (-5.85%)

MGNX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

91.80% (6.74%)

86.00% (-9.57%)

95.10% (-1.55%)

96.60% (-3.40%)

Profit Margin

-44.70% (-190.26%)

-15.40% (80.46%)

-78.80% (69.81%)

-261.00% (-110.99%)

EBITDA Margin

-38.70% (-511.70%)

9.40% (113.24%)

-71.00% (71.19%)

-246.40% (-119.41%)

Return on Average Equity (ROAE)

-66.90% (-1053.45%)

-5.80% (92.91%)

-81.80% (-21.55%)

-67.30% (-33.00%)

Return on Average Assets (ROAA)

-27.50% (-882.14%)

-2.80% (94.35%)

-49.60% (2.55%)

-50.90% (-31.87%)

Return on Sales (ROS)

-43.30% (-233.08%)

-13.00% (83.50%)

-78.80% (69.81%)

-261.00% (-110.99%)

Return on Invested Capital (ROIC)

-72.10% (-1797.37%)

-3.80% (95.31%)

-81.00% (28.95%)

-114.00% (-32.71%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-3.04 (95.26%)

-64.13 (-1763.79%)

-3.44 (27.76%)

-4.76 (48.54%)

Price to Sales Ratio (P/S)

1.36 (-86.62%)

10.14 (273.79%)

2.71 (-78.16%)

12.42 (8.69%)

Price to Book Ratio (P/B)

1.76 (-55.04%)

3.91 (34.60%)

2.9 (-29.20%)

4.1 (-5.50%)

Debt to Equity Ratio (D/E)

1.25 (31.41%)

0.95 (-2.05%)

0.97 (144.36%)

0.4 (42.50%)

Earnings Per Share (EPS)

-1.07 (-613.33%)

-0.15 (92.31%)

-1.95 (42.14%)

-3.37 (-36.44%)

Sales Per Share (SPS)

2.4 (152.37%)

0.95 (-61.63%)

2.47 (91.41%)

1.29 (-35.40%)

Free Cash Flow Per Share (FCFPS)

-1.15 (11.01%)

-1.29 (12.48%)

-1.47 (41.11%)

-2.5 (-11.44%)

Book Value Per Share (BVPS)

1.85 (-24.80%)

2.46 (6.57%)

2.31 (-42.16%)

4 (-29.16%)

Tangible Assets Book Value Per Share (TABVPS)

4.18 (-13.30%)

4.82 (5.56%)

4.57 (-18.38%)

5.59 (-22.56%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (98.59%)

-71 (-2266.67%)

-3 (25.00%)

-4 (55.56%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.01 (-101.02%)

98.25 (3123.85%)

-3.25 (24.30%)

-4.29 (54.52%)

Asset Turnover

0.61 (236.07%)

0.18 (-70.95%)

0.63 (223.08%)

0.2 (-37.50%)

Current Ratio

3.92 (-12.57%)

4.48 (-1.99%)

4.57 (21.93%)

3.75 (-39.23%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$71,919,000 (9.99%)

-$79,905,000 (11.79%)

-$90,582,000 (39.62%)

-$150,031,000 (-27.36%)

Enterprise Value (EV)

$58,456,206 (-89.19%)

$540,934,280 (54.32%)

$350,527,733 (-57.21%)

$819,205,916 (-26.31%)

Earnings Before Tax (EBT)

-$66,022,000 (-628.88%)

-$9,058,000 (92.44%)

-$119,758,000 (40.75%)

-$202,115,000 (-55.79%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$58,030,000 (-1153.94%)

$5,506,000 (105.10%)

-$107,893,000 (43.47%)

-$190,857,000 (-62.04%)

Invested Capital

$60,746,000 (-65.35%)

$175,325,000 (11.10%)

$157,805,000 (-2.99%)

$162,666,000 (-7.67%)

Working Capital

$161,960,000 (-17.04%)

$195,231,000 (12.48%)

$173,569,000 (-15.32%)

$204,982,000 (-21.74%)

Tangible Asset Value

$261,655,000 (-12.32%)

$298,418,000 (6.40%)

$280,468,000 (-16.34%)

$335,245,000 (-11.48%)

Market Capitalization

$203,981,206 (-65.82%)

$596,723,280 (44.66%)

$412,498,733 (-58.04%)

$983,190,916 (-23.48%)

Average Equity

$100,024,000 (-36.23%)

$156,851,250 (7.13%)

$146,416,500 (-51.22%)

$300,158,000 (17.04%)

Average Assets

$243,892,250 (-24.23%)

$321,885,250 (33.38%)

$241,325,750 (-39.24%)

$397,190,250 (18.02%)

Invested Capital Average

$89,984,500 (-55.16%)

$200,666,500 (35.72%)

$147,851,250 (-16.59%)

$177,260,000 (17.41%)

Shares

62,763,448 (1.18%)

62,029,447 (0.90%)

61,475,221 (0.35%)

61,258,001 (8.99%)